- Journalists Talk Hot Health Topics: Urgent Care Clinics Performing Abortions and Doulas’ Pay
- ASCs’ vendor problem
- Providence’s physician chief on its ‘holistic’ approach to value-based care
- What the Health? From KFF Health News: A New CDC Nominee, Again
- States Update Guardianship Laws To Keep Children of Immigrants Out of Foster Care
- Anesthesia job market faces ‘major disruption’
- Florida system raises $100M for new ED
- North Carolina system names COO
- Mark Cuban wants to bring drug manufacturing to hospitals’ doorsteps — literally
- UCI Health names chief AI officer
- Nevada hospital names CEO
- Saint Luke’s taps president for 2 hospitals
- Dental community mourns dentist killed in murder-suicide
- Mass General Brigham, CVS deal could raise healthcare spending $40M annually: Report
- Ideal Dental opens 1st Oklahoma practice, expands in 2 more states
- PDS Health eyes the next era of medical-dental integration
- Mark Cuban dives into direct contracting
- HCA executive pay by the numbers
- Iris Telehealth offers behavioral health analytics platform
- HHS names chief economist, regulatory leader to address healthcare affordability
- Loma Linda University Health names new president
- The best ASCs for colonoscopy, endoscopy in the South: US News
- Tennessee moves forward with CON repeal
- Dental schools take action to alleviate workforce shortages: 6 updates
- American Medical Group Association partners with Talkiatry to expand psych access
- Trump nominates CDC director
- ChristianaCare, Cardiovascular Physicians of Delaware to open joint venture ASC
- 5 states regulating AI in mental health
- Centerstone debuts $13M youth behavioral health campus in Missouri
- 3 DSOs making headlines
- Maine restricts noncompetes for rural healthcare workers
- Heartland Dental opens Florida office
- The 10 biggest ASC deals of the last 5 years
- Affordability, transparency: A look at large employers' top healthcare concerns
- 10 dental Medicaid updates to know from Q1
- White House eyes ibogaine research expansion
- New Weight Loss Research Questions Need for GLP-1 Drugs
- Trump Names CDC Director Pick
- SocialRx teams up with FQHC in NYC to prescribe arts and culture for chronically ill patients
- FDA To Review Whether To Allow More Access To Certain Peptides
- Rising Colon Cancer Deaths Hit Younger Adults Without Degrees Hardest
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Over 80% of PCPs concerned about financial stability over next several years
- Industry Voices—DOJ jumps into 340B cases over state law, raising questions about federal plans for the program
- FDA's accelerated approval pathway needs stronger transparency, evidence standards: ICER
- Most People Would Take A Blood Test For Alzheimer's, Study Says
- This Sexually Transmitted Infection Linked To Heart Attack, Stroke
- How Playtime at Age 2, Especially with Parents, Shapes Teen Fitness Habits
- New Depression Treatment Matches ECT with Less Memory Loss, Study Says
- Memory Problems? Your Salt Intake Could Make Matters Worse, Study Says
- Ultra-Processed Foods Linked To Fatty Muscles, Potential Knee Arthritis
- Your New Therapist: Chatty, Leaky, and Hardly Human
- Teva scores in appeal as court revives $177M verdict against Lilly in migraine patent spat
- Gen AI chatbots continually struggle with differential diagnoses, Mass General Brigham study finds
- Listen: With Little Federal Regulation, States Are Left To Shape the Rules on AI in Health Care
- Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale
- BIO comes out swinging with 'Fight of Our Lives' campaign for the industry’s 50th birthday
- The future of medical-dental integration is here
- Texas dentist has license suspended
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- What’s the deal with insurer mental health parity violations?
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- Verily Health simplifies medical jargon alphabet soup with AI-powered app in new campaign
- 10 trends in behavioral health usage: Report
- Cattywampus: Statement on the CAT Concept Release
- Providers' advantage on out-of-network billing disputes likely to continue: Capstone
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- APA launches resource library for trusted digital mental health tools
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- EPA Delays Decisions on 'Forever Chemicals'
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- Progyny unveils new fertility benefit option for small, mid-size employers
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- Hospitals with more disadvantaged patients fall short on price transparency, study finds
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- Listen to the Latest ‘KFF Health News Minute’
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Does Your Child Have Nightmares? Here's One Solution
- Marriage's Hidden Benefit? A Lower Risk Of Cancer
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- Statement Regarding Staff No-Action Letter to Bank of England
LARA's licensing process is heavily weighted on the entry side, with very little real supervision after licensing. Dr. Farid T. Fata should never have been licensed in Michigan, and his license should have been revoked well before his arrest in 2013.
An experienced oncology nurse, Angela Swantek, interviewed at Dr. Fata's Michigan Hematology-Oncology (MHO) in 2010 and saw practices that were "plain wrong". Ms. Swantek was convinced that MHO was drugging patients solely to bill their insurance companies for extravagant fees. She filed a complaint with LARA, but got no response until 2011, when LARA sent her a form letter saying that there was no evidence to support an investigation into Fata. An MHO office manager, George Karadsheh, echoed Ms. Swantek's allegations in 2013, finally leading to Dr. Fata's arrest:
https://thecinemaholic.com/farid-fata-where-is-the-fraudster-now/
Farid Fata: Where is the Fraudster Now?
By Sounak Sengupta - June 17, 2023NBC’s ‘Dateline: Do No Harm’ follows the criminal antiques of fraudster, Dr. Farid Fata, as he was convicted of medical malpractice and other charges in August 2013 in Michigan. Rather than treating or easing the suffering of his cancer patients, he administered a combination of chemical infusions and injections with potentially harmful and deadly side effects for his financial benefit. So, how was Farid caught, and where is he now? Let’s find out.
Who is Farid Fata?
Farid T. Fata was born to a Melkite Catholic family in Lebanon in 1965. He secured a medical degree in his native country in 1992 before migrating to the United States to pursue a career in medical science. He served a residency at Maimonides Medical Center in Brooklyn, New York, from 1993 to 1996 and then as a fellow in hematology-oncology at Memorial Sloan Kettering Cancer Center in Manhattan until 1999. Farid worked as an attending physician at Geisinger Medical Center in Danville, Pennsylvania, from 2000 to 2003.
He opened his solely owned practice, Michigan Hematology-Oncology (MHO), at 543 North Main Street in 2003 in Rochester Hills, Michigan. What started as a small, single physician office expanded over the following decade and grew to six more locations — Clarkston, Bloomfield Hills, Lapeer, Sterling Heights, Troy, and Oak Park. Farid became a naturalized U.S. citizen in April 2009. By the time he was arrested in 2013, MHO had 16,000 historical patients and 1,700 current patients — the vast majority of whom belonged to Farid.
Court records underlined how he accomplished this astonishing growth using several means. His business documents and employee testimonies state Farid was seeing as many as 50-60 patients per day, scheduled in eight-minute increments. He employed non-licensed physicians with medical degrees from foreign countries to work them up before he saw them for five-ten minutes, billing at the two highest levels for office visits. Patients waited for hours at a time before they were ushered in.
According to an oncology supply company representative supplying most of his drugs, Farid worked on a plan to compete with large practices. His medicine orders skyrocketed in a year to over $7 million, then $16 million. He ordered in bulk at the end of quarters to reach the threshold for contractual discounts. Reports stated an average doctor in an oncology practice purchases approximately $1.5 million of drugs in a given year. However, when he was arrested, MHO bought $45 million for only three doctors.
A sentencing memorandum stated how Farid expanded his businesses to include a radiation treatment center, Michigan Radiation Institute (MRI); an in-house pharmacy at MHO’s Rochester Hills location, Vital Pharmacare (Vital); a diagnostic testing facility, United Diagnostics; and a charity located at MHO and staffed by social workers and grant writers, Swan for Life. Farid specialized in treating blood cancer and earned a sterling reputation as one of the best cancer specialists in the Detroit area.
According to the episode, he created a niche for himself with his aggressive treatment procedures that involved giving higher doses of chemotherapy drugs more frequently — he termed it the “European protocol.” Farid’s erstwhile wife, Samar, helped run the business side of his practice as Chief Executive Officer and Chief Financial Officer of his companies. According to an ensuing investigation, the federal officers termed Farid the most egregious fraudster in the history of this country.
Where is Farid Fata Now?
His misdemeanors were not solely limited to the millions of dollars he stole but also the harm he inflicted on more than 500 patients. Some of Farid’s misdemeanors include deliberately misdiagnosing patients with multiple myeloma, administering unrequired chemotherapy to patients, lying to them about the availability of alternative treatments, and ordering infusion times increased beyond what was medically necessary or advisable purely to increase his reimbursement.
The episode showed how there had been signs about his malpractice, which included a civil suit filed by a patient in 2007 and a veteran oncology nurse complaining to the state authorities in 2010. However, Farid’s schemes began to unravel in July 2013 when one of his 54-year-old patients, Monica Flagg, broke her leg and went to a suburban Detroit-area hospital for treatment. Farid, who had diagnosed her with multiple myeloma, was on vacation in Lebanon, and one of his doctors, Soe Maunglay, attended to Monica at MHO.
Soe could find no indication for the chemotherapy and supportive care medications. Reports stated he was already on notice after catching Farid lying about the clinic’s enrollment in a professional quality program. Suspicious, Soe began investigating some of Farid’s other cases, which included excessive use of rituximab and IVIG. During his probe, he contacted Farid’s practice manager, George Karadsheh, whose inspection supported Soe’s suspicions. George went to the Department of Justice and was interviewed on August 2, 2013.
The federal agents interviewed several staff members of MHO and corroborated the claims made by the whistleblowers — George and Soe. They arrested Farid and charged him with 19 counts of healthcare fraud and other crimes. Originally held on a $170,000 bond, the federal authorities discovered he and his wife had assets of $9 million not yet seized. Fearing him a flight risk, a federal judge raised Farid’s bond to $9 million. The Federal Bureau of Investigation confiscated thousands of medical charts.
They amassed evidence that he had used dishonest measures to trick the patients’ insurance companies and Medicare into paying $34 million in fraudulent and unnecessary claims. The officers also discovered that Farid took kickbacks from two local hospices and poured Medicare and private insurance proceeds into his diagnostic testing facility. They filed a 23-count indictment charging him with healthcare fraud, conspiracy to take and receive kickbacks, money laundering, and unlawfully procuring naturalization. Facing a maximum of 175 years in prison and the prospect of losing citizenship, Farid decided to take a plea deal.
He pled guilty in September 2014 to 16 federal charges — 13 counts of health care fraud, two counts of money laundering, and one count of conspiring to pay and receive kickbacks and cash payments for referring patients to a particular hospice and home health care company. He was sentenced to 45 years in federal prison and agreed to forfeit millions of dollars in assets to pay restitution to former patients or their families, approximately $17.6 million. The 58-year-old is incarcerated at Federal Correctional Institution, Williamsburg in South Carolina, and will not be released before December 2050.
What a saga. Who knew charisma/mystique could completely deceive so many people about their own health?
I also wonder how much he skewed regional/state cancer statistics. Is his fraud the reason Michigan has "hot spots" for certain types of cancer?
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














